BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36338055)

  • 1. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome.
    Yang Z; Fu H; Su H; Cai X; Wang Y; Hong Y; Hu J; Xie Z; Wang X
    Front Microbiol; 2022; 13():1017147. PubMed ID: 36338055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model.
    Ho B; Ryback D; Benson B; Mason CN; Torres PJ; Quinn RA; Thackray VG; Kelley ST
    mSystems; 2021 Oct; 6(5):e0114920. PubMed ID: 34519532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
    Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
    Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
    [No Abstract]   [Full Text] [Related]  

  • 4. Probiotic
    Zhang J; Sun Z; Jiang S; Bai X; Ma C; Peng Q; Chen K; Chang H; Fang T; Zhang H
    mSystems; 2019; 4(2):. PubMed ID: 31020040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
    Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
    Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.
    Li G; Liu Z; Ren F; Shi H; Zhao Q; Song Y; Fan X; Ma X; Qin G
    Front Microbiol; 2022; 13():911992. PubMed ID: 35847083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
    Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
    J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis.
    Li RJ; Jie ZY; Feng Q; Fang RL; Li F; Gao Y; Xia HH; Zhong HZ; Tong B; Madsen L; Zhang JH; Liu CL; Xu ZG; Wang J; Yang HM; Xu X; Hou Y; Brix S; Kristiansen K; Yu XL; Jia HJ; He KL
    Front Cell Infect Microbiol; 2021; 11():708088. PubMed ID: 34692558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
    Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
    Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study.
    Yu Z; Qin E; Cheng S; Yang H; Liu R; Xu T; Liu Y; Yuan J; Yu S; Yang J; Liang F
    Sci Rep; 2022 Dec; 12(1):22184. PubMed ID: 36564416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of host-gut microbiome interactions in multiple sclerosis.
    Cantoni C; Lin Q; Dorsett Y; Ghezzi L; Liu Z; Pan Y; Chen K; Han Y; Li Z; Xiao H; Gormley M; Liu Y; Bokoliya S; Panier H; Suther C; Evans E; Deng L; Locca A; Mikesell R; Obert K; Newland P; Wu Y; Salter A; Cross AH; Tarr PI; Lovett-Racke A; Piccio L; Zhou Y
    EBioMedicine; 2022 Feb; 76():103798. PubMed ID: 35094961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
    Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
    Front Physiol; 2022; 13():887077. PubMed ID: 35800349
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary Syndrome.
    Zhou J; Qiu X; Chen X; Ma S; Chen Z; Wang R; Tian Y; Jiang Y; Fan L; Wang J
    J Microbiol; 2023 Sep; 61(9):821-836. PubMed ID: 37824034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.
    Zhao L; Wang C; Peng S; Zhu X; Zhang Z; Zhao Y; Zhang J; Zhao G; Zhang T; Heng X; Zhang L
    J Transl Med; 2022 Oct; 20(1):459. PubMed ID: 36209079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery.
    Han Y; Kim G; Ahn E; Jung S; Jung Y; Kim Y; Ha E; Heo Y; Ryu DH; Park H; Hwang GS
    Diabetes Obes Metab; 2022 Jul; 24(7):1224-1234. PubMed ID: 35257467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.
    Clos-Garcia M; Andrés-Marin N; Fernández-Eulate G; Abecia L; Lavín JL; van Liempd S; Cabrera D; Royo F; Valero A; Errazquin N; Vega MCG; Govillard L; Tackett MR; Tejada G; Gónzalez E; Anguita J; Bujanda L; Orcasitas AMC; Aransay AM; Maíz O; López de Munain A; Falcón-Pérez JM
    EBioMedicine; 2019 Aug; 46():499-511. PubMed ID: 31327695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
    Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
    Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
    Liang Z; Di N; Li L; Yang D
    J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
    Rizk MG; Thackray VG
    J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.
    Mukherjee AG; Wanjari UR; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Dey A; Babu A; Renu K; Vellingiri B; Ramanathan G; Priya Doss C G; Elsherbiny N; Elsherbini AM; Alsamman AM; Zayed H; Gopalakrishnan AV
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.